| Year |
Citation |
Score |
| 2020 |
De Koninck M, Lapi E, Badía-Careaga C, Cossío I, Giménez-Llorente D, Rodríguez-Corsino M, Andrada E, Hidalgo A, Manzanares M, Real FX, Losada A. Essential Roles of Cohesin STAG2 in Mouse Embryonic Development and Adult Tissue Homeostasis. Cell Reports. 32: 108014. PMID 32783938 DOI: 10.1016/J.Celrep.2020.108014 |
0.325 |
|
| 2020 |
van Rhijn BWG, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, et al. FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?. European Urology. PMID 32682615 DOI: 10.1016/J.Eururo.2020.07.002 |
0.369 |
|
| 2020 |
Font A, Domènech M, Benítez R, Rava M, Marqués M, Ramírez JL, Pineda S, Domínguez-Rodríguez S, Gago JL, Badal J, Carrato C, López H, Quer A, Castellano D, Malats N, ... Real FX, et al. Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy. Cancers. 12. PMID 32635360 DOI: 10.3390/Cancers12071784 |
0.355 |
|
| 2020 |
Hruschka N, Kalisz M, Subijana M, Graña-Castro O, Del Cano-Ochoa F, Brunet LP, Chernukhin I, Sagrera A, De Reynies A, Kloesch B, Chin SF, Burgués O, Andreu D, Bermejo B, Cejalvo JM, ... ... Real FX, et al. The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver. Oncogene. PMID 32587399 DOI: 10.1038/S41388-020-1376-3 |
0.357 |
|
| 2020 |
Richart L, Felipe I, Delgado P, Andrés MP, Prieto J, Pozo ND, García JF, Piris MA, Ramiro A, Real FX. Bptf determines oncogenic addiction in aggressive B-cell lymphomas. Oncogene. PMID 32451433 DOI: 10.1038/S41388-020-1331-3 |
0.338 |
|
| 2020 |
Kalisz M, Bernardo E, Beucher A, Maestro MA, Del Pozo N, Millán I, Haeberle L, Schlensog M, Safi SA, Knoefel WT, Grau V, de Vas M, Shpargel KB, Vaquero E, Magnuson T, ... ... Real FX, et al. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. The Embo Journal. e102808. PMID 32154941 DOI: 10.15252/Embj.2019102808 |
0.391 |
|
| 2020 |
Kamoun A, de Reyniès A, Allory Y, Sjödahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, ... ... Real FX, et al. Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press. European Urology. PMID 32037144 DOI: 10.1016/J.Eururo.2019.12.014 |
0.301 |
|
| 2019 |
Rodríguez-Seguel E, Villamayor L, Arroyo N, De Andrés MP, Real FX, Martín F, Cano DA, Rojas A. Loss of GATA4 causes ectopic pancreas in the stomach. The Journal of Pathology. PMID 31875961 DOI: 10.1002/Path.5378 |
0.33 |
|
| 2019 |
Kamoun A, Reyniès A, Allory Y, Sjödahl G, Gordon Robertson A, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, ... ... Real FX, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. European Urology. PMID 31563503 DOI: 10.1016/J.Eururo.2019.09.006 |
0.308 |
|
| 2019 |
Santos CP, Lapi E, Martínez de Villarreal J, Álvaro-Espinosa L, Fernández-Barral A, Barbáchano A, Domínguez O, Laughney AM, Megías D, Muñoz A, Real FX. Urothelial organoids originating from Cd49f mouse stem cells display Notch-dependent differentiation capacity. Nature Communications. 10: 4407. PMID 31562298 DOI: 10.1038/S41467-019-12307-1 |
0.31 |
|
| 2019 |
Fernández-Barral A, Costales-Carrera A, Buira SP, Jung P, Ferrer-Mayorga G, Larriba MJ, Bustamante-Madrid P, Domínguez O, Real FX, Pastrián LG, Lafarga M, García-Olmo D, Cantero R, Del Peso L, Batlle E, et al. Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids. The Febs Journal. PMID 31306552 DOI: 10.1111/Febs.14998 |
0.319 |
|
| 2019 |
Martinelli P, Real FX. Mouse Models Shed Light on the SLIT/ROBO Pathway in Pancreatic Development and Cancer. Trends in Cancer. 5: 145-148. PMID 30898261 DOI: 10.1016/J.Trecan.2019.02.004 |
0.37 |
|
| 2019 |
Rubio C, Martínez-Fernández M, Segovia C, Lodewijk I, Suarez-Cabrera C, Segrelles C, López-Calderón F, Munera-Maravilla E, Santos M, Bernardini A, García-Escudero R, Lorz C, Gómez-Rodriguez MJ, de Velasco G, Otero I, ... ... Real FX, et al. CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of Status. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 390-402. PMID 30242024 DOI: 10.1158/1078-0432.Ccr-18-0685 |
0.325 |
|
| 2019 |
Rhijn Bv, Mertens L, Mayr R, Bostrom P, Marquez M, Zwarthoff E, Boormans J, Abas C, Leenders Gv, Gotz S, Bertz S, Neuzillet Y, Sanders J, Broeks A, Heijden Mvd, ... ... Real F, et al. Pd52-02 Fgfr3 Mutations And Their Relation To Fgfr3 Expression And Clinical Outcome In A Large Radical Cystectomy Cohort: Implications For Anti-Fgfr3 Bladder Cancer Treatment? European Urology Supplements. 201. DOI: 10.1097/01.Ju.0000556958.45525.C0 |
0.305 |
|
| 2018 |
Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, Childs EJ, Collins I, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Canzian F, Duell EJ, ... ... Real FX, et al. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Journal of the National Cancer Institute. PMID 30541042 DOI: 10.1093/Jnci/Djy155 |
0.342 |
|
| 2018 |
Gomez-Rubio P, Piñero J, Molina-Montes E, Gutiérrez-Sacristán A, Marquez M, Rava M, Michalski CW, Farré A, Molero X, Löhr M, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, ... ... Real FX, et al. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. International Journal of Cancer. PMID 30229903 DOI: 10.1002/Ijc.31866 |
0.309 |
|
| 2018 |
Real FX, de Andrés MP. Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe. Trends in Cancer. 4: 399-401. PMID 29860982 DOI: 10.1016/J.Trecan.2018.04.004 |
0.343 |
|
| 2018 |
Scarpa A, Real FX, Luchini C. Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management. Gut. 67: 1561-1563. PMID 29661802 DOI: 10.1136/Gutjnl-2018-316151 |
0.363 |
|
| 2018 |
Cobo I, Martinelli P, Flández M, Bakiri L, Zhang M, Carrillo-de-Santa-Pau E, Jia J, Sánchez-Arévalo Lobo VJ, Megías D, Felipe I, Del Pozo N, Millán I, Thommesen L, Bruland T, Olson SH, ... ... Real FX, et al. Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas. Nature. PMID 29443959 DOI: 10.1038/Nature25751 |
0.342 |
|
| 2018 |
Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, ... ... Real FX, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications. 9: 556. PMID 29422604 DOI: 10.1038/S41467-018-02942-5 |
0.389 |
|
| 2018 |
Van Kessel KE, van der Keur KA, Dyrskjøt L, Algaba F, Welvaart NY, Beukers W, Segersten U, Keck B, Maurer T, Simic T, Horstmann M, Grimm MO, Hermann GG, Mogensen K, Hartmann A, ... ... Real FX, et al. Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29367430 DOI: 10.1158/1078-0432.Ccr-17-2719 |
0.333 |
|
| 2018 |
Molina-Montes E, Gomez-Rubio P, Márquez M, Rava M, Löhr M, Michalski CW, Molero X, Farré A, Perea J, Greenhalf W, Ilzarbe L, O'Rorke M, Tardón A, Gress T, Barberà VM, ... ... Real FX, et al. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. International Journal of Epidemiology. PMID 29329392 DOI: 10.1093/Ije/Dyx269 |
0.365 |
|
| 2017 |
Niell N, Larriba MJ, Ferrer-Mayorga G, Sánchez-Pérez I, Cantero R, Real FX, Del Peso L, Muñoz A, González-Sancho JM. The human PKP2/Plakophilin-2 gene is induced by Wnt/β-catenin in normal and colon cancer-associated fibroblasts. International Journal of Cancer. PMID 29044515 DOI: 10.1002/Ijc.31104 |
0.334 |
|
| 2017 |
Notta F, Hahn SA, Real FX. A genetic roadmap of pancreatic cancer: still evolving. Gut. PMID 28993418 DOI: 10.1136/Gutjnl-2016-313317 |
0.406 |
|
| 2017 |
Petronczki MP, van der Lelij P, Lieb S, Jude J, Wutz G, Santos CP, Falkenberg K, Schlattl A, Ban J, Schwentner R, Hoffmann T, Kovar H, Real FX, Waldman T, Pearson MA, et al. Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts. Elife. 6. PMID 28691904 DOI: 10.7554/Elife.26980 |
0.397 |
|
| 2017 |
Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, ... ... Real FX, et al. Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study. European Urology. PMID 28583312 DOI: 10.1016/J.Eururo.2017.05.040 |
0.342 |
|
| 2017 |
Gomez-Rubio P, Rosato V, Marquez M, Bosetti C, Molina-Montes E, Rava M, Piñero J, Michalski CW, Farré A, Molero X, Löhr M, Ilzarbe L, Perea J, Greenhalf W, O'Rorke M, ... ... Real FX, et al. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28383714 DOI: 10.1093/Annonc/Mdx167 |
0.326 |
|
| 2017 |
Choi W, Ochoa A, McConkey DJ, Aine M, Höglund M, Kim WY, Real FX, Kiltie AE, Milsom I, Dyrskjøt L, Lerner SP. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. European Urology. PMID 28365159 DOI: 10.1016/J.Eururo.2017.03.010 |
0.383 |
|
| 2017 |
Marqués M, Real FX. PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets. European Urology. 71: 863-865. PMID 28214032 DOI: 10.1016/J.Eururo.2017.01.049 |
0.306 |
|
| 2017 |
Sánchez-Arévalo Lobo VJ, Fernández LC, Carrillo-de-Santa-Pau E, Richart L, Cobo I, Cendrowski J, Moreno U, Del Pozo N, Megías D, Bréant B, Wright CV, Magnuson M, Real FX. c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis. Gut. PMID 28159836 DOI: 10.1136/Gutjnl-2016-312306 |
0.353 |
|
| 2017 |
Beukers W, van der Keur KA, Kandimalla R, Vergouwe Y, Steyerberg EW, Boormans JL, Jensen JB, Lorente JA, Real FX, Segersten U, Orntoft TF, Malats N, Malmström PU, Dyrskjot L, Zwarthoff EC. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study. The Journal of Urology. 197: 1410-1418. PMID 28049011 DOI: 10.1016/J.Juro.2016.12.096 |
0.375 |
|
| 2017 |
Lelij Pvd, Lieb S, Jude J, Wutz G, Santos CP, Falkenberg K, Schlattl A, Ban J, Schwentner R, Hoffmann T, Kovar H, Real FX, Waldman T, Pearson MA, Kraut N, et al. Author response: Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts Elife. DOI: 10.7554/Elife.26980.026 |
0.334 |
|
| 2017 |
Lelij PVD, Lieb S, Jude J, Wutz G, Pereira C, Falkenberg K, Ban J, Kovar H, Waldman T, Real F, Pearson M, Kraut N, Peters J, Zuber J, Petronczki MP. Abstract 3452: The cohesin subunitSTAG1is a hardwired genetic dependency ofSTAG2mutant cancer cells Cancer Research. 77: 3452-3452. DOI: 10.1158/1538-7445.Am2017-3452 |
0.431 |
|
| 2017 |
Santos CP, Lapi E, Álvaro L, Barbáchano A, Barral A, Muñoz A, Real FX. CD49f labels an organoid-forming mouse urothelial cell population with stem cell features Urologic Oncology-Seminars and Original Investigations. 35: 617. DOI: 10.1016/J.Urolonc.2017.06.032 |
0.307 |
|
| 2017 |
Lapi E, Santos CP, Sjödahl G, Höglund M, Losada A, Real FX. Shedding light into the role of STAG2 in urothelial bladder cancer Urologic Oncology-Seminars and Original Investigations. 35: 615. DOI: 10.1016/J.Urolonc.2017.06.025 |
0.326 |
|
| 2017 |
Domínguez S, Rava M, Sirab N, Tardón A, Carrato A, Serra C, García-Closas R, Rothman N, Silverman D, Kogevinas M, Allory Y, Real FX, Malats N. Specific risk patterns for bladder cancer taxonomy-based subphenotypes Urologic Oncology-Seminars and Original Investigations. 35: 611. DOI: 10.1016/J.Urolonc.2017.06.013 |
0.347 |
|
| 2017 |
Rubio PG, Molina-Montes E, Marquez M, Rava M, Michalski CW, Farré A, Molero X, Löhr M, Ilzarbe L, Perea J, Greenhalf W, Tardón A, Gress T, Barberà VM, Crnogorac-Jurcevic T, ... ... Real FX, et al. A reduced risk of pancreatic cancer risk is observed among subjects with autoimmune diseases Pancreatology. 17. DOI: 10.1016/J.Pan.2017.05.308 |
0.329 |
|
| 2017 |
Molina-Montes E, Rosato V, Gomez-Rubio P, Löhr M, Michalski CW, Molero X, Marquez M, Ilzarbe L, Farre A, Perea J, Greenhalf W, O’Rorke M, Tardón A, Gress T, Barbera VM, ... ... Real FX, et al. Association between gallbladder disease and pancreatic cancer risk according to tumour characteristics Pancreatology. 17. DOI: 10.1016/J.Pan.2017.05.305 |
0.382 |
|
| 2016 |
Millán-Uclés Á, Zuluaga S, Marqués M, Vallejo-Díaz J, Sanz L, Cariaga-Martínez AE, Real FX, Carrera AC. E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencing. Oncotarget. 7: 84054-84071. PMID 27863432 DOI: 10.18632/Oncotarget.13414 |
0.331 |
|
| 2016 |
Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, ... ... Real FX, et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. PMID 27732578 DOI: 10.1038/Nature19823 |
0.411 |
|
| 2016 |
Gubern A, Joaquin M, Marquès M, Maseres P, Garcia-Garcia J, Amat R, González-Nuñez D, Oliva B, Real FX, de Nadal E, Posas F. The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells. Molecular Cell. 64: 25-36. PMID 27642049 DOI: 10.1016/J.Molcel.2016.08.015 |
0.357 |
|
| 2016 |
Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B, Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N, Büchler M, Pajic M, Biankin AV, Iovanna J, Neoptolemos J, ... Real FX, et al. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut. PMID 27325420 DOI: 10.1136/Gutjnl-2015-311256 |
0.383 |
|
| 2016 |
Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, ... ... Real FX, et al. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. Cancer Cell. PMID 27321955 DOI: 10.1016/J.Ccell.2016.05.004 |
0.376 |
|
| 2016 |
López de Maturana E, Picornell A, Masson-Lecomte A, Kogevinas M, Márquez M, Carrato A, Tardón A, Lloreta J, García-Closas M, Silverman D, Rothman N, Chanock S, Real FX, Goddard ME, Malats N, et al. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models. Bmc Cancer. 16: 351. PMID 27259534 DOI: 10.1186/S12885-016-2361-7 |
0.317 |
|
| 2016 |
Masson-Lecomte A, López de Maturana E, Goddard ME, Picornell A, Rava M, Gonzalez-Neira A, Marquez M, Carrato A, Tardon A, Lloreta J, Garcia-Closas M, Silverman D, Rothman N, Kogevinas M, Allory Y, ... ... Real FX, et al. Inflammatory-related genetic variants in non-muscle invasive bladder cancer prognosis. A multi-marker Bayesian assessment. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197286 DOI: 10.1158/1055-9965.Epi-15-0894 |
0.378 |
|
| 2016 |
Zhou W, Machiela MJ, Freedman ND, Rothman N, Malats N, Dagnall C, Caporaso N, Teras LT, Gaudet MM, Gapstur SM, Stevens VL, Jacobs KB, Sampson J, Albanes D, Weinstein S, ... ... Real FX, et al. Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nature Genetics. PMID 27064253 DOI: 10.1038/Ng.3545 |
0.363 |
|
| 2016 |
Ferrer J, Real FX. The cis-regulatory switchboard of pancreatic ductal cancer. The Embo Journal. 35: 558-60. PMID 26893390 DOI: 10.15252/Embj.201693999 |
0.335 |
|
| 2016 |
Mazarico JM, Sánchez-Arévalo Lobo VJ, Favicchio R, Greenhalf W, Costello E, Carrillo-de Santa Pau E, Marqués M, Lacal JC, Aboagye E, Real FX. Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors. Molecular Cancer Therapeutics. 15: 323-33. PMID 26769123 DOI: 10.1158/1535-7163.Mct-15-0214 |
0.334 |
|
| 2016 |
Fernández LC, Torres M, Real FX. Somatic mosaicism: on the road to cancer. Nature Reviews. Cancer. 16: 43-55. PMID 26678315 DOI: 10.1038/Nrc.2015.1 |
0.363 |
|
| 2016 |
Martinelli P, Madriles F, Cañamero M, Pau EC, Pozo ND, Guerra C, Real FX. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice. Gut. 65: 476-86. PMID 25596178 DOI: 10.1136/Gutjnl-2014-308042 |
0.324 |
|
| 2016 |
Kessel KEMv, Keur KAvd, Dyrskjøt L, Algaba F, Welvaart N, Beukers W, Segersten U, Keck B, Maurer T, Simic T, Horstmann M, Boormans JL, Real FX, Malats N, Malmström P, et al. Abstract 428: Hypermethylation of GATA2 is validated as a marker of progression in non-muscle invasive bladder cancer Cancer Research. 76: 428-428. DOI: 10.1158/1538-7445.Am2016-428 |
0.366 |
|
| 2016 |
Molina-Montes E, Gómez-Rubio P, Barberà VM, Carrato A, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Farré A, Greenhalf W, Gress T, Hidalgo M, Ilzarbe L, Michalski CW, Löhr M, Marquez M, Molero X, ... ... Real FX, et al. Familiy history of cancer and diabetes and pancreatic cancer risk Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.391 |
0.363 |
|
| 2016 |
Gomez-Rubio P, Molina-Montes E, Barberà VM, Carrato A, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Farré A, Greenhalf W, Gress T, Hidalgo M, Ilzarbe L, Michalski CW, Löhr M, Marquez M, Molero X, ... ... Real FX, et al. Oral health and pancreatic cancer risk Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.385 |
0.342 |
|
| 2016 |
Gomez-Rubio P, Pińero J, Gutiérrez-Sacristán A, Real FX, Furlong LI, Malats N. Common genetic background of pancreatic cancer associated morbidities Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.382 |
0.373 |
|
| 2016 |
Guillén-Ponce C, Ferreiro R, Pachon V, Earl J, Lopez MTS, Calcedo C, Marques M, Vázquez-Sequeiros E, Muñoz-Beltran M, Sanjuanbenito A, Real F, Malats N, Carrato A. The Spanish national familial pancreatic cancer registry Pan-Gen-FAM: Screening of high-risk individuals for the early detection of a pancreatic tumor Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.295 |
0.357 |
|
| 2016 |
Earl J, Guillèn-Ponce C, Ferreiro R, Pachon V, Lopez MTS, Calcedo C, Martinez-Avila JC, Marquez M, Rodríguez-Garrote M, Vázquez-Sequeiros E, Muñoz-Beltran M, Real F, Malats N, Carrato A. Circulating free tumor DNA (cftDNA) as a novel biomarker for the early detection of cancer in familial pancreatic cancer families Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.085 |
0.352 |
|
| 2016 |
Cobo I, Flandez M, Pozo ND, Melia J, Real FX. NR5A2 pancreatic haploinsufficiency cooperates with mutant Kras in the development of aggressive cystic tumors Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.064 |
0.301 |
|
| 2016 |
Martinelli P, Pau ECS, Cox T, Saint B, Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N, Büchler M, Jovanna J, Neoptolemos J, Real F. GATA6 regulates EMT and tumor dissemination, and correlates with response to chemotherapy in pancreatic cancer Pancreatology. 16. DOI: 10.1016/J.Pan.2016.05.035 |
0.373 |
|
| 2015 |
Takaori K, Bassi C, Biankin A, Brunner TB, Cataldo I, Campbell F, Cunningham D, Falconi M, Frampton AE, Furuse J, Giovannini M, Jackson R, Nakamura A, Nealon W, Neoptolemos JP, ... Real FX, et al. International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 26699808 DOI: 10.1016/J.Pan.2015.10.013 |
0.341 |
|
| 2015 |
Gomez-Rubio P, Zock JP, Rava M, Marquez M, Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X, Farré A, Perea J, Greenhalf W, O'Rorke M, Tardón A, ... ... Real FX, et al. Reduced risk of pancreatic cancer associated with asthma and nasal allergies. Gut. PMID 26628509 DOI: 10.1136/Gutjnl-2015-310442 |
0.314 |
|
| 2015 |
Gerdtsson AS, Malats N, Säll A, Real FX, Porta M, Skoog P, Persson H, Wingren C, Borrebaeck CA. A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. International Journal of Proteomics. 2015: 587250. PMID 26587286 DOI: 10.1155/2015/587250 |
0.328 |
|
| 2015 |
Barbáchano A, Fernández-Barral A, Pereira F, Segura MF, Ordóñez-Morán P, Carrillo-de Santa Pau E, González-Sancho JM, Hanniford D, Martínez N, Costales-Carrera A, Real FX, Pálmer HG, Rojas JM, Hernando E, Muñoz A. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. PMID 26455323 DOI: 10.1038/Onc.2015.366 |
0.36 |
|
| 2015 |
Figueroa JD, Koutros S, Colt JS, Kogevinas M, Garcia-Closas M, Real FX, Friesen MC, Baris D, Stewart P, Schwenn M, Johnson A, Karagas MR, Armenti KR, Moore LE, Schned A, et al. Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. Journal of the National Cancer Institute. 107. PMID 26374428 DOI: 10.1093/Jnci/Djv223 |
0.355 |
|
| 2015 |
Pérez-García A, Pérez-Durán P, Wossning T, Sernandez IV, Mur SM, Cañamero M, Real FX, Ramiro AR. AID-expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathway. Embo Molecular Medicine. 7: 1327-36. PMID 26282919 DOI: 10.15252/Emmm.201505348 |
0.325 |
|
| 2015 |
Mocci E, Guillen-Ponce C, Earl J, Marquez M, Solera J, Salazar-López MT, Calcedo-Arnáiz C, Vázquez-Sequeiros E, Montans J, Muñoz-Beltrán M, Vicente-Bártulos A, González-Gordaliza C, Sanjuanbenito A, Guerrero C, Mendía E, ... ... Real FX, et al. PanGen-Fam: Spanish registry of hereditary pancreatic cancer. European Journal of Cancer (Oxford, England : 1990). 51: 1911-7. PMID 26212471 DOI: 10.1016/J.Ejca.2015.07.004 |
0.378 |
|
| 2015 |
Earl J, Rico D, Carrillo-de-Santa-Pau E, Rodríguez-Santiago B, Méndez-Pertuz M, Auer H, Gómez G, Grossman HB, Pisano DG, Schulz WA, Pérez-Jurado LA, Carrato A, Theodorescu D, Chanock S, Valencia A, ... Real FX, et al. The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies. Bmc Genomics. 16: 403. PMID 25997541 DOI: 10.1186/S12864-015-1450-3 |
0.392 |
|
| 2015 |
Malats N, Real FX. Epidemiology of bladder cancer. Hematology/Oncology Clinics of North America. 29: 177-89, vii. PMID 25836927 DOI: 10.1016/J.Hoc.2014.10.001 |
0.333 |
|
| 2015 |
Maraver A, Fernandez-Marcos PJ, Cash TP, Mendez-Pertuz M, Dueñas M, Maietta P, Martinelli P, Muñoz-Martin M, Martínez-Fernández M, Cañamero M, Roncador G, Martinez-Torrecuadrada JL, Grivas D, de la Pompa JL, Valencia A, ... ... Real FX, et al. NOTCH pathway inactivation promotes bladder cancer progression. The Journal of Clinical Investigation. 125: 824-30. PMID 25574842 DOI: 10.1172/Jci78185 |
0.394 |
|
| 2015 |
Hidalgo M, Cascinu S, Kleeff J, Labianca R, Löhr JM, Neoptolemos J, Real FX, Van Laethem JL, Heinemann V. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. 15: 8-18. PMID 25547205 DOI: 10.1016/J.Pan.2014.10.001 |
0.347 |
|
| 2015 |
Cendrowski J, Lobo VJ, Sendler M, Salas A, Kühn JP, Molero X, Fukunaga R, Mayerle J, Lerch MM, Real FX. Mnk1 is a novel acinar cell-specific kinase required for exocrine pancreatic secretion and response to pancreatitis in mice. Gut. 64: 937-47. PMID 25037190 DOI: 10.1136/Gutjnl-2013-306068 |
0.313 |
|
| 2015 |
Gerlinger M, Catto JW, Orntoft TF, Real FX, Zwarthoff EC, Swanton C. Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications. European Urology. 67: 729-37. PMID 24836153 DOI: 10.1016/J.Eururo.2014.04.014 |
0.354 |
|
| 2015 |
Dueñas M, Martínez-Fernández M, García-Escudero R, Villacampa F, Marqués M, Saiz-Ladera C, Duarte J, Martínez V, Gómez MJ, Martín ML, Fernández M, Castellano D, Real FX, Rodriguez-Peralto JL, De La Rosa F, et al. PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors. Molecular Carcinogenesis. 54: 566-76. PMID 24347284 DOI: 10.1002/Mc.22125 |
0.362 |
|
| 2015 |
Guillen C, Earl J, Mocci E, Guerrero C, Montans J, Marquez M, Sequeiros EV, Gordaliza CG, Sanjuanbenito A, MuÑoz MJ, Solera J, Real FX, Malats N, Carrato A. Genetic and phenotypic characterization of families with familial pancreatic cancer and screening of high-risk individuals. Journal of Clinical Oncology. 33: 242-242. DOI: 10.1200/Jco.2015.33.3_Suppl.242 |
0.364 |
|
| 2015 |
Kessel KEMv, Beukers W, Lurkin I, Keur KAvd, Dyrskjot L, Segersten U, Ørntoft TF, Malats N, Malmström P, Real FX, Bangma CH, Zwarthoff EC. Abstract 549: A urine based assay to select patients for initial cystoscopy Cancer Research. 75: 549-549. DOI: 10.1158/1538-7445.Am2015-549 |
0.337 |
|
| 2015 |
Guillèn-Ponce C, Earl J, Lopez MTS, Calcedo C, Ferreiro R, Mocci E, Guerrero C, Montans J, Marquez M, Gordaliza CG, Beltrán MM, Sequeiros EV, Sanjuanbenito A, García JS, Real F, et al. The Spanish familial pancreatic cancer registry panfam: Screening of high-risk individuals Pancreatology. 15. DOI: 10.1016/J.Pan.2015.05.442 |
0.332 |
|
| 2015 |
Gomez-Rubio P, Scarpa A, Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X, Farré A, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberà V, ... ... Real FX, et al. Patterns of comorbidity and multimorbidity in pancreatic cancer patients Pancreatology. 15. DOI: 10.1016/J.Pan.2015.05.441 |
0.362 |
|
| 2015 |
Gomez-Rubio P, Zock J, Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X, Farré A, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberà V, ... ... Real FX, et al. Asthma and nasal allergies associate with reduced pancreatic cancer risk Pancreatology. 15. DOI: 10.1016/J.Pan.2015.05.439 |
0.332 |
|
| 2015 |
Takaori K, Bassi C, Biankin A, Brunner T, Cataldo I, Campbell F, Cunningham D, Falconi M, Frampton AE, Furuse J, Giovannini M, Jackson R, Nakamura A, Nealon W, Neoptolemos JP, ... Real F, et al. Perspectives of International Association of Pancreatology (IAP)/European Pancreas Club (EPC) consensus review of guidelines for the future studies on clinical management of pancreatic cancer Pancreatology. 15. DOI: 10.1016/J.Pan.2015.05.401 |
0.331 |
|
| 2015 |
Martinelli P, Sainz B, Pau ECS, Rinaldi L, Pozo Nd, Real FX. GATA 3/6 control tissue-specific epithelial programmes and a basal-like phenotype in multiple cancer types, including PDAC Pancreatology. 15. DOI: 10.1016/J.Pan.2015.05.137 |
0.348 |
|
| 2015 |
Malats N, Milne RL, Lerch MM, Greenhalf W, Canzian F, Farre A, Rosendahl J, Molero X, Barmada MM, Camp D, Chanock SJ, Flández M, Giese N, Johnstone M, Kogevinas M, ... ... Real FX, et al. Genetic variants associated with PDAC also contribute to chronic pancreatitis susceptibility Pancreatology. 15. DOI: 10.1016/J.Pan.2015.05.091 |
0.3 |
|
| 2014 |
Hoskins JW, Jia J, Flandez M, Parikh H, Xiao W, Collins I, Emmanuel MA, Ibrahim A, Powell J, Zhang L, Malats N, Bamlet WR, Petersen GM, Real FX, Amundadottir LT. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Carcinogenesis. 35: 2670-8. PMID 25233928 DOI: 10.1093/Carcin/Bgu193 |
0.398 |
|
| 2014 |
Masson-Lecomte A, Rava M, Real FX, Hartmann A, Allory Y, Malats N. Inflammatory biomarkers and bladder cancer prognosis: a systematic review. European Urology. 66: 1078-91. PMID 25151017 DOI: 10.1016/J.Eururo.2014.07.033 |
0.339 |
|
| 2014 |
Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, et al. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Gastroenterology. 147: 1119-33.e4. PMID 25127677 DOI: 10.1053/J.Gastro.2014.08.002 |
0.335 |
|
| 2014 |
Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, ... ... Real FX, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nature Genetics. 46: 994-1000. PMID 25086665 DOI: 10.1038/Ng.3052 |
0.302 |
|
| 2014 |
Whissell G, Montagni E, Martinelli P, Hernando-Momblona X, Sevillano M, Jung P, Cortina C, Calon A, Abuli A, Castells A, Castellvi-Bel S, Nacht AS, Sancho E, Stephan-Otto Attolini C, Vicent GP, ... Real FX, et al. The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression. Nature Cell Biology. 16: 695-707. PMID 24952462 DOI: 10.1038/Ncb2992 |
0.337 |
|
| 2014 |
Vedder MM, Márquez M, de Bekker-Grob EW, Calle ML, Dyrskjøt L, Kogevinas M, Segersten U, Malmström PU, Algaba F, Beukers W, Ørntoft TF, Zwarthoff E, Real FX, Malats N, Steyerberg EW. Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours. Plos One. 9: e96849. PMID 24905984 DOI: 10.1371/Journal.Pone.0096849 |
0.331 |
|
| 2014 |
Pineda S, Milne RL, Calle ML, Rothman N, López de Maturana E, Herranz J, Kogevinas M, Chanock SJ, Tardón A, Márquez M, Guey LT, GarcÃa-Closas M, Lloreta J, Baum E, González-Neira A, ... ... Real FX, et al. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis. Plos One. 9: e89952. PMID 24818791 DOI: 10.1371/Journal.Pone.0089952 |
0.328 |
|
| 2014 |
Tajuddin SM, Amaral AF, Fernández AF, Chanock S, Silverman DT, Tardón A, Carrato A, GarcÃa-Closas M, Jackson BP, Toraño EG, Márquez M, Urdinguio RG, GarcÃa-Closas R, Rothman N, Kogevinas M, ... Real FX, et al. LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk. British Journal of Cancer. 110: 2123-30. PMID 24595004 DOI: 10.1038/Bjc.2014.67 |
0.311 |
|
| 2014 |
Allory Y, Beukers W, Sagrera A, Flández M, Marqués M, Márquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, Carrato A, Lloreta J, Lorente JA, Carrillo-de Santa Pau E, Masius RG, ... ... Real FX, et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. European Urology. 65: 360-6. PMID 24018021 DOI: 10.1016/J.Eururo.2013.08.052 |
0.333 |
|
| 2014 |
Flandez M, Cendrowski J, Cañamero M, Salas A, del Pozo N, Schoonjans K, Real FX. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis. Gut. 63: 647-55. PMID 23598351 DOI: 10.1136/Gutjnl-2012-304381 |
0.316 |
|
| 2013 |
de Maturana EL, Ye Y, Calle ML, Rothman N, Urrea V, Kogevinas M, Petrus S, Chanock SJ, Tardón A, GarcÃa-Closas M, González-Neira A, Vellalta G, Carrato A, Navarro A, Lorente-Galdós B, ... ... Real FX, et al. Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk. Plos One. 8: e83745. PMID 24391818 DOI: 10.1371/Journal.Pone.0083745 |
0.388 |
|
| 2013 |
Balbás-MartÃnez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Márquez M, Vazquez M, Lapi E, Castro-Giner F, Beltran S, Bayés M, Carrato A, Cigudosa JC, DomÃnguez O, Gut M, Herranz J, ... ... Real FX, et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nature Genetics. 45: 1464-9. PMID 24121791 DOI: 10.1038/Ng.2799 |
0.401 |
|
| 2013 |
Balbás-MartÃnez C, RodrÃguez-Pinilla M, Casanova A, DomÃnguez O, Pisano DG, Gómez G, Lloreta J, Lorente JA, Malats N, Real FX. ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors. Plos One. 8: e62483. PMID 23650517 DOI: 10.1371/Journal.Pone.0062483 |
0.346 |
|
| 2013 |
Wauters E, Sanchez-Arévalo Lobo VJ, Pinho AV, Mawson A, Herranz D, Wu J, Cowley MJ, Colvin EK, Njicop EN, Sutherland RL, Liu T, Serrano M, Bouwens L, Real FX, Biankin AV, et al. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. Cancer Research. 73: 2357-67. PMID 23370328 DOI: 10.1158/0008-5472.Can-12-3359 |
0.395 |
|
| 2013 |
Robles C, Viscidi R, Malats N, Silverman DT, Tardon A, Garcia-Closas R, Serra C, Carrato A, Herranz J, Lloreta J, Rothman N, Real FX, de Sanjose S, Kogevinas M. Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: the Spanish bladder cancer study. International Journal of Cancer. Journal International Du Cancer. 133: 597-603. PMID 23355322 DOI: 10.1002/Ijc.28053 |
0.409 |
|
| 2013 |
Martinelli P, Cañamero M, del Pozo N, Madriles F, Zapata A, Real FX. Gata6 is required for complete acinar differentiation and maintenance of the exocrine pancreas in adult mice. Gut. 62: 1481-8. PMID 23002247 DOI: 10.1136/Gutjnl-2012-303328 |
0.344 |
|
| 2013 |
Guillen-Ponce C, Mocci E, Earl J, Marquez M, Milne R, Molina-Garrido M, Guerrero CT, Real FX, Malats N, Carrato A. Imaging techniques in pancreatic cancer screening: Preliminary results from the PanGen-FAM registry. Journal of Clinical Oncology. 31: 1529-1529. DOI: 10.1200/Jco.2013.31.15_Suppl.1529 |
0.342 |
|
| 2012 |
Guillen-Ponce C, Mocci E, Marquez M, Earl J, Guerrero CT, Salazar MT, Calcedo MC, Real FX, Malats N, Carrato A. Spanish registry and screening program for families at high risk of pancreatic adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 192. PMID 27983457 DOI: 10.1200/Jco.2012.30.4_Suppl.192 |
0.35 |
|
| 2012 |
Amaral AF, Méndez-Pertuz M, Muñoz A, Silverman DT, Allory Y, Kogevinas M, Lloreta J, Rothman N, Carrato A, Rivas del Fresno M, Real FX, Malats N. Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. Journal of the National Cancer Institute. 104: 1897-904. PMID 23108201 DOI: 10.1093/Jnci/Djs444 |
0.323 |
|
| 2012 |
Czachorowski MJ, Amaral AF, Montes-Moreno S, Lloreta J, Carrato A, Tardón A, Morente MM, Kogevinas M, Real FX, Malats N. Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis. Plos One. 7: e45025. PMID 23028744 DOI: 10.1371/Journal.Pone.0045025 |
0.328 |
|
| 2012 |
Dyrskjøt L, Reinert T, Novoradovsky A, Zuiverloon TC, Beukers W, Zwarthoff E, Malats N, Real FX, Segersten U, Malmström PU, Knowles M, Hurst C, Sorge J, Borre M, Orntoft TF. Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR. British Journal of Cancer. 107: 1392-8. PMID 22976798 DOI: 10.1038/Bjc.2012.412 |
0.35 |
|
| 2012 |
Marenne G, Real FX, Rothman N, Rodríguez-Santiago B, Pérez-Jurado L, Kogevinas M, García-Closas M, Silverman DT, Chanock SJ, Génin E, Malats N. Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data. Bmc Genomics. 13: 326. PMID 22817656 DOI: 10.1186/1471-2164-13-326 |
0.3 |
|
| 2012 |
Porta M, Pumarega J, Guarner L, Malats N, Solà R, Real FX. Relationships of hepatic and pancreatic biomarkers with the cholestatic syndrome and tumor stage in pancreatic cancer. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 17: 557-65. PMID 22793268 DOI: 10.3109/1354750X.2012.701331 |
0.321 |
|
| 2012 |
Ruppen-Cañás I, López-Casas PP, García F, Ximénez-Embún P, Muñoz M, Morelli MP, Real FX, Serna A, Hidalgo M, Ashman K. An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity. Proteomics. 12: 1319-27. PMID 22589181 DOI: 10.1002/Pmic.201100611 |
0.324 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, ... ... Real FX, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics. 44: 651-8. PMID 22561519 DOI: 10.1038/Ng.2270 |
0.382 |
|
| 2012 |
Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, Malats N, Tang W, Liu L, Garcia-Closas M, Muchmore B, Chatterjee N, Tarway M, Kogevinas M, Porter-Gill P, ... ... Real FX, et al. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proceedings of the National Academy of Sciences of the United States of America. 109: 4974-9. PMID 22416122 DOI: 10.1073/Pnas.1202189109 |
0.315 |
|
| 2012 |
Menashe I, Figueroa JD, Garcia-Closas M, Chatterjee N, Malats N, Picornell A, Maeder D, Yang Q, Prokunina-Olsson L, Wang Z, Real FX, Jacobs KB, Baris D, Thun M, Albanes D, et al. Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background. Plos One. 7: e29396. PMID 22238607 DOI: 10.1371/Journal.Pone.0029396 |
0.332 |
|
| 2012 |
Amaral AF, Porta M, Silverman DT, Milne RL, Kogevinas M, Rothman N, Cantor KP, Jackson BP, Pumarega JA, López T, Carrato A, Guarner L, Real FX, Malats N. Pancreatic cancer risk and levels of trace elements. Gut. 61: 1583-8. PMID 22184070 DOI: 10.1136/Gutjnl-2011-301086 |
0.326 |
|
| 2012 |
Ortiz-Zapater E, Pineda D, Martínez-Bosch N, Fernández-Miranda G, Iglesias M, Alameda F, Moreno M, Eliscovich C, Eyras E, Real FX, Méndez R, Navarro P. Key contribution of CPEB4-mediated translational control to cancer progression. Nature Medicine. 18: 83-90. PMID 22138752 DOI: 10.1038/Nm.2540 |
0.348 |
|
| 2012 |
Molero X, Vaquero EC, Flández M, González AM, Ortiz MÃ, Cibrián-Uhalte E, Servitja JM, Merlos A, Juanpere N, Massumi M, Skoudy A, Macdonald R, Ferrer J, Real FX. Gene expression dynamics after murine pancreatitis unveils novel roles for Hnf1α in acinar cell homeostasis. Gut. 61: 1187-96. PMID 21948943 DOI: 10.1136/Gutjnl-2011-300360 |
0.335 |
|
| 2012 |
Rooman I, Real FX. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Gut. 61: 449-458. PMID 21730103 DOI: 10.1136/Gut.2010.235804 |
0.341 |
|
| 2012 |
Maturana ELd, Mata D, Herránz J, Rothman N, Calle ML, Picornell AC, Garcia-Closas M, Kogevinas M, Carrato A, Tardón A, Real FX, Silverman D, Chanock S, Malats N. Low predictive ability of low penetrance genetic variants for bladder cancer risk among non-smokers F1000research. 3. DOI: 10.7490/F1000Research.1092279.1 |
0.344 |
|
| 2012 |
Guillen-Ponce C, Mocci E, Earl J, Guerrero CT, Calcedo MC, Salazar MT, Molina-Garrido M, Marquez M, Gordaliza CG, Sequeiros EV, Custodio A, Real FX, Malats N, Carrato A. Spanish national hereditary pancreatic cancer registry (PanFAM). Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E12033 |
0.366 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Hoover RN, Real FX, Fraumeni JF, Caporaso NE, Tucker M, Rothman N, Pérez-Jurado LA, Chanock SJ. Abstract 3110: The aging genome: Genetic mosaicism and its relationship to cancer Cancer Research. 72: 3110-3110. DOI: 10.1158/1538-7445.Am2012-3110 |
0.312 |
|
| 2012 |
Tajuddin SM, Amaral AFS, Fernandez AF, Moore L, Silverman DT, Kogevinas M, Rothman N, Real FX, Fraga MF, Malats N. 1157 Association of LINE-1 Methylation With Risk of Bladder Cancer in the Spanish Population European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)71753-7 |
0.328 |
|
| 2012 |
Prokunina-Olsson L, Fu Y, Tang W, Figueroa J, Kohaar I, Earl J, Silverman D, Wu X, Real F, Rothman N. 755 From Genome-wide Association Studies to Translational Genomics of Bladder Cancer European Journal of Cancer. 48: S179. DOI: 10.1016/S0959-8049(12)71391-6 |
0.302 |
|
| 2011 |
Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Human Molecular Genetics. 20: 4282-9. PMID 21824976 DOI: 10.1093/Hmg/Ddr342 |
0.319 |
|
| 2011 |
Zhong Y, Wang Z, Fu B, Pan F, Yachida S, Dhara M, Albesiano E, Li L, Naito Y, Vilardell F, Cummings C, Martinelli P, Li A, Yonescu R, Ma Q, ... ... Real FX, et al. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. Plos One. 6: e22129. PMID 21811562 DOI: 10.1371/Journal.Pone.0022129 |
0.401 |
|
| 2011 |
Pinho AV, Rooman I, Real FX. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle. 10: 1312-1321. PMID 21490434 DOI: 10.4161/Cc.10.8.15363 |
0.335 |
|
| 2011 |
Alguacil J, Kogevinas M, Silverman DT, Malats N, Real FX, GarcÃa-Closas M, Tardón A, Rivas M, Torà M, GarcÃa-Closas R, Serra C, Carrato A, Pfeiffer RM, Fortuny J, Samanic C, et al. Urinary pH, cigarette smoking and bladder cancer risk. Carcinogenesis. 32: 843-7. PMID 21402590 DOI: 10.1093/Carcin/Bgr048 |
0.322 |
|
| 2011 |
Pinho AV, Rooman I, Reichert M, De Medts N, Bouwens L, Rustgi AK, Real FX. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut. 60: 958-66. PMID 21193456 DOI: 10.1136/Gut.2010.225920 |
0.355 |
|
| 2011 |
García-Closas M, Hein DW, Silverman D, Malats N, Yeager M, Jacobs K, Doll MA, Figueroa JD, Baris D, Schwenn M, Kogevinas M, Johnson A, Chatterjee N, Moore LE, Moeller T, ... Real FX, et al. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenetics and Genomics. 21: 231-6. PMID 20739907 DOI: 10.1097/Fpc.0B013E32833E1B54 |
0.301 |
|
| 2011 |
Fu Y, Kohaar I, Mumy A, Tang W, Muchmore B, Porter-Gill P, Liu L, Figueroa J, Garcia-Closas M, Baris D, Purdue M, Thun M, Albanes D, Malats N, Real FX, et al. A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk Genome Biology. 12: 4. DOI: 10.1186/Gb-2011-12-S1-P4 |
0.356 |
|
| 2011 |
Jia J, Frank N, Parikh H, Flandez M, Collins I, Hussain P, Lo K, Petersen GM, Real F, Ammundadottir L. Abstract 4965: Genome analysis of a pancreatic cancer susceptibility locus in the NR5A2 gene on chromosome 1q32.1 Cancer Research. 71: 4965-4965. DOI: 10.1158/1538-7445.Am2011-4965 |
0.445 |
|
| 2011 |
Tang W, Fu Y, Liu L, Orduz N, Kaushiva A, Mumy A, Porter-Gill P, Meyers T, Garcia-Closas M, Malats N, Chanock S, Real FX, Kogevinas M, Rothman N, Silverman D, et al. Abstract 4680: Exploring the relationships between genetic variants within the UGT1A locus, cellular detoxification and risk of bladder cancer Cancer Research. 71: 4680-4680. DOI: 10.1158/1538-7445.Am2011-4680 |
0.4 |
|
| 2011 |
Fu Y, Kohaar I, Muchmore B, Mumy A, Tang W, Porter-Gill P, Garcia-Closas M, Chanock S, Figueroa J, Baris D, Purdue M, Thun M, Albanes D, Malats N, Real FX, et al. Abstract 2783: A novel functional variant is associated with regulation of the prostate stem cell antigen (PSCA) gene and bladder cancer risk in males Cancer Research. 71: 2783-2783. DOI: 10.1158/1538-7445.Am2011-2783 |
0.377 |
|
| 2010 |
Hafner C, Toll A, Fernández-Casado A, Earl J, Marqués M, Acquadro F, Méndez-Pertuz M, Urioste M, Malats N, Burns JE, Knowles MA, Cigudosa JC, Hartmann A, Vogt T, Landthaler M, ... ... Real FX, et al. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proceedings of the National Academy of Sciences of the United States of America. 107: 20780-5. PMID 21078999 DOI: 10.1073/Pnas.1008365107 |
0.328 |
|
| 2010 |
MacDonald RJ, Swift GH, Real FX. Transcriptional control of acinar development and homeostasis. Progress in Molecular Biology and Translational Science. 97: 1-40. PMID 21074728 DOI: 10.1016/B978-0-12-385233-5.00001-5 |
0.321 |
|
| 2010 |
Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nature Genetics. 42: 978-84. PMID 20972438 DOI: 10.1038/Ng.687 |
0.306 |
|
| 2010 |
Cantor KP, Villanueva CM, Silverman DT, Figueroa JD, Real FX, Garcia-Closas M, Malats N, Chanock S, Yeager M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Samanic C, et al. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environmental Health Perspectives. 118: 1545-50. PMID 20675267 DOI: 10.1289/Ehp.1002206 |
0.319 |
|
| 2010 |
Rodríguez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, Kogevinas M, Villa O, Hutchinson A, Earl J, Marenne G, Jacobs K, Rico D, Tardón A, Carrato A, Thomas G, ... ... Real FX, et al. Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. American Journal of Human Genetics. 87: 129-38. PMID 20598279 DOI: 10.1016/J.Ajhg.2010.06.002 |
0.315 |
|
| 2010 |
Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, Rothman N, Vellalta G, Calle ML, Marenne G, Tardón A, Carrato A, García-Closas R, Serra C, Silverman DT, ... ... Real FX, et al. Genetic susceptibility to distinct bladder cancer subphenotypes. European Urology. 57: 283-92. PMID 19692168 DOI: 10.1016/J.Eururo.2009.08.001 |
0.355 |
|
| 2010 |
Amaral AFS, Rothman N, Kogevinas M, Calle ML, Guey LT, García-Closas M, Silverman DT, Chanock S, Real FX, Riera NMi. Selenoproteins and bladder cancer risk: A case-control study Toxicology Letters. 196. DOI: 10.1016/J.Toxlet.2010.03.207 |
0.345 |
|
| 2009 |
Porta M, López T, Pumarega J, Jariod M, Crous-Bou M, Marco E, Rifà J, Grimalt JO, Malats N, Real FX. In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations Mutagenesis. 24: 513-521. PMID 19797353 DOI: 10.1093/Mutage/Gep037 |
0.309 |
|
| 2009 |
MartÃnez-Romero C, Rooman I, Skoudy A, Guerra C, Molero X, González A, Iglesias M, Lobato T, Bosch A, Barbacid M, Real FX, Hernández-Muñoz I. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma. The Journal of Pathology. 219: 205-13. PMID 19585519 DOI: 10.1002/Path.2585 |
0.381 |
|
| 2009 |
Milne RL, Greenhalf W, Murta-Nascimento C, Real FX, Malats N. The Inherited Genetic Component of Sporadic Pancreatic Adenocarcinoma Pancreatology. 9: 206-214. PMID 19352090 DOI: 10.1159/000210261 |
0.343 |
|
| 2009 |
Baudot A, Real FX, Izarzugaza JM, Valencia A. From cancer genomes to cancer models: bridging the gaps. Embo Reports. 10: 359-66. PMID 19305388 DOI: 10.1038/Embor.2009.46 |
0.361 |
|
| 2009 |
Roda O, Ortiz-Zapater E, Martínez-Bosch N, Gutiérrez-Gallego R, Vila-Perelló M, Ampurdanés C, Gabius HJ, André S, Andreu D, Real FX, Navarro P. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Gastroenterology. 136: 1379-90, e1-5. PMID 19171142 DOI: 10.1053/J.Gastro.2008.12.039 |
0.317 |
|
| 2009 |
Pujal J, Huch M, José A, Abasolo I, Rodolosse A, Duch A, Sánchez-Palazón L, Smith FJ, McLean WH, Fillat C, Real FX. Keratin 7 promoter selectively targets transgene expression to normal and neoplastic pancreatic ductal cells in vitro and in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 1366-75. PMID 19124560 DOI: 10.1096/Fj.08-115576 |
0.347 |
|
| 2009 |
Castillejo A, Rothman N, Murta-Nascimento C, Malats N, García-Closas M, Gómez-Martínez A, Lloreta J, Tardón A, Serra C, García-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, ... ... Real FX, et al. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. International Journal of Cancer. 124: 608-13. PMID 19004027 DOI: 10.1002/Ijc.24013 |
0.341 |
|
| 2009 |
Villanueva CM, Silverman DT, Murta-Nascimento C, Malats N, Garcia-Closas M, Castro F, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M. Coffee consumption, genetic susceptibility and bladder cancer risk Cancer Causes and Control. 20: 121-127. PMID 18798002 DOI: 10.1007/S10552-008-9226-6 |
0.314 |
|
| 2008 |
Toll A, Real FX. Somatic oncogenic mutations, benign skin lesions and cancer progression: where to look next? Cell Cycle. 7: 2674-2681. PMID 18728396 DOI: 10.4161/Cc.7.17.6523 |
0.364 |
|
| 2008 |
Rovira M, Delaspre F, Massumi M, Serra SA, Valverde MA, Lloreta J, Dufresne M, Payré B, Konieczny SF, Savatier P, Real FX, Skoudy A. Murine embryonic stem cell-derived pancreatic acinar cells recapitulate features of early pancreatic differentiation. Gastroenterology. 135: 1301-1310, 1310.e1-5. PMID 18725222 DOI: 10.1053/J.Gastro.2008.06.049 |
0.363 |
|
| 2008 |
Hernández-Muñoz I, Skoudy A, Real FX, Navarro P. Pancreatic Ductal Adenocarcinoma: Cellular Origin, Signaling Pathways and Stroma Contribution Pancreatology. 8: 462-469. PMID 18724072 DOI: 10.1159/000151537 |
0.381 |
|
| 2008 |
Real FX, Cibrián–Uhalte E, Martinelli P. Pancreatic cancer development and progression: remodeling the model. Gastroenterology. 135: 724-728. PMID 18692502 DOI: 10.1053/J.Gastro.2008.07.033 |
0.378 |
|
| 2008 |
Figueroa JD, Malats N, García-Closas M, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Lan Q, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, et al. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis. 29: 1955-62. PMID 18632753 DOI: 10.1093/Carcin/Bgn163 |
0.381 |
|
| 2008 |
Silverman DT, Alguacil J, Rothman N, Real FX, Garcia-Closas M, Cantor KP, Malats N, Tardon A, Serra C, Garcia-Closas R, Carrato A, Lloreta J, Samanic C, Dosemeci M, Kogevinas M. Does increased urination frequency protect against bladder cancer? International Journal of Cancer. 123: 1644-1648. PMID 18623081 DOI: 10.1002/Ijc.23572 |
0.359 |
|
| 2008 |
Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, GarcÃa-Closas R, Chanock S, Tardón A, Serra C, Carrato A, Dosemeci M, GarcÃa-Closas M, Esteller M, Fraga M, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. The Lancet. Oncology. 9: 359-66. PMID 18339581 DOI: 10.1016/S1470-2045(08)70038-X |
0.362 |
|
| 2008 |
Samanic CM, Kogevinas M, Silverman DT, Tardón A, Serra C, Malats N, Real FX, Carrato A, García-Closas R, Sala M, Lloreta J, Rothman N, Dosemeci M. Occupation and bladder cancer in a hospital-based case-control study in Spain Occupational and Environmental Medicine. 65: 347-353. PMID 17951336 DOI: 10.1136/Oem.2007.035816 |
0.337 |
|
| 2008 |
Garcia-Rojo D, Malats N, Murta-Nascimento C, Silverman DT, Prats J, Garcia-Closas M, Tardon A, Serra C, Garcia-Closas R, Carrato A, Dosemeci M, Real FX. Risk Of Bladder Cancer Associated With Family History Of Cancer: Do Low-Penetrance Polymorphisms Account For The Increse In Risk? The Journal of Urology. 179: 322-323. DOI: 10.1016/S0022-5347(08)60944-1 |
0.36 |
|
| 2007 |
Real FX. p53: it has it all, but will it make it to the clinic as a marker in bladder cancer? Journal of Clinical Oncology. 25: 5341-5344. PMID 18048811 DOI: 10.1200/Jco.2007.13.1904 |
0.354 |
|
| 2007 |
Michaud DS, Kogevinas M, Cantor KP, Villanueva CM, Garcia-Closas M, Rothman N, Malats N, Real FX, Serra C, Garcia-Closas R, Tardon A, Carrato A, Dosemeci M, Silverman DT. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer Environmental Health Perspectives. 115: 1569-1572. PMID 18007986 DOI: 10.1289/Ehp.10281 |
0.33 |
|
| 2007 |
Castaño-Vinyals G, Talaska G, Rothman N, Alguacil J, Garcia-Closas M, Dosemeci M, Cantor KP, Malats N, Real FX, Silverman D, Serra C, Carrato A, Tardon A, Garcia-Closas R, Kogevinas M, et al. Bulky DNA adduct formation and risk of bladder cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2155-9. PMID 17932365 DOI: 10.1158/1055-9965.Epi-07-0184 |
0.329 |
|
| 2007 |
Rovira M, Jané-Valbuena J, Marchand M, Savatier P, Real FX, Skoudy A. Viral-mediated coexpression of Pdx1 and p48 regulates exocrine pancreatic differentiation in mouse ES cells. Cloning and Stem Cells. 9: 327-338. PMID 17907943 DOI: 10.1089/Clo.2006.0064 |
0.353 |
|
| 2007 |
Molero X, Adell T, Skoudy A, Padilla MA, Gómez JA, Chalaux E, Malagelada JR, Real FX. Pancreas transcription factor 1alpha expression is regulated in pancreatitis. European Journal of Clinical Investigation. 37: 791-801. PMID 17888090 DOI: 10.1111/J.1365-2362.2007.01856.X |
0.677 |
|
| 2007 |
Murta-Nascimento C, Silverman DT, Kogevinas M, García-Closas M, Rothman N, Tardón A, García-Closas R, Serra C, Carrato A, Villanueva C, Dosemeci M, Real FX, Malats N. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1595-600. PMID 17684133 DOI: 10.1158/1055-9965.Epi-06-0743 |
0.376 |
|
| 2007 |
Strom A, Bonal C, Ashery-Padan R, Hashimoto N, Campos ML, Trumpp A, Noda T, Kido Y, Real FX, Thorel F, Herrera PL. Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas. Development. 134: 2719-2725. PMID 17596282 DOI: 10.1242/Dev.02875 |
0.311 |
|
| 2007 |
Dyrskjøt L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, Kotwal S, Knowles M, Malmström PU, de la Torre M, Wester K, Allory Y, Vordos D, Caillault A, Radvanyi F, et al. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3545-51. PMID 17575217 DOI: 10.1158/1078-0432.Ccr-06-2940 |
0.346 |
|
| 2007 |
Figueroa JD, Malats N, Rothman N, Real FX, Silverman D, Kogevinas M, Chanock S, Yeager M, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis. 28: 1788-93. PMID 17557904 DOI: 10.1093/Carcin/Bgm132 |
0.343 |
|
| 2007 |
Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World Journal of Urology. 25: 285-295. PMID 17530260 DOI: 10.1007/S00345-007-0168-5 |
0.402 |
|
| 2007 |
Ortiz-Zapater E, Peiró S, Roda O, Corominas JM, Aguilar S, Ampurdanés C, Real FX, Navarro P. Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2 American Journal of Pathology. 170: 1573-1584. PMID 17456763 DOI: 10.2353/Ajpath.2007.060850 |
0.374 |
|
| 2007 |
Pascual M, Abasolo I, Mingorance-Le Meur A, MartÃnez A, Del Rio JA, Wright CV, Real FX, Soriano E. Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expression. Proceedings of the National Academy of Sciences of the United States of America. 104: 5193-8. PMID 17360405 DOI: 10.1073/Pnas.0605699104 |
0.317 |
|
| 2007 |
García-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D, Kogevinas M, Dosemeci M, Figueroa J, Chatterjee N, Tardón A, Serra C, Carrato A, García-Closas R, Murta-Nascimento C, et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. Plos Genetics. 3: e29. PMID 17319747 DOI: 10.1371/Journal.Pgen.0030029 |
0.362 |
|
| 2007 |
Mayo C, Lloreta J, Real FX, Mayol X. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression. Journal of Cellular Physiology. 212: 42-50. PMID 17311291 DOI: 10.1002/Jcp.20999 |
0.38 |
|
| 2007 |
Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, García-Closas R, Silverman D, Chanock S, Welch R, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. International Journal of Cancer. Journal International Du Cancer. 120: 2452-8. PMID 17311259 DOI: 10.1002/Ijc.22565 |
0.377 |
|
| 2007 |
Luis NM, López-Knowles E, Real FX. Molecular biology of bladder cancer. Clinical & Translational Oncology. 9: 5-12. PMID 17272224 DOI: 10.1007/S12094-007-0003-X |
0.369 |
|
| 2007 |
Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Rothman N, García-Closas M. Genetic variation in the base excision repair pathway and bladder cancer risk. Human Genetics. 121: 233-42. PMID 17203305 DOI: 10.1007/S00439-006-0294-Y |
0.358 |
|
| 2007 |
Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Marcos R, Rothman N, Real FX, Dosemeci M, Kogevinas M. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools American Journal of Epidemiology. 165: 148-156. PMID 17079692 DOI: 10.1093/Aje/Kwj364 |
0.302 |
|
| 2006 |
López-Knowles E, Hernández S, Kogevinas M, Lloreta J, Amorós A, Tardón A, Carrato A, Kishore S, Serra C, Malats N, Real FX. The p53 pathway and outcome among patients with T1G3 bladder tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6029-36. PMID 17062677 DOI: 10.1158/1078-0432.Ccr-06-0206 |
0.327 |
|
| 2006 |
Treiber M, Schulz HU, Landt O, Drenth JP, Castellani C, Real FX, Akar N, Ammann RW, Bargetzi M, Bhatia E, Demaine AG, Battagia C, Kingsnorth A, O'Reilly D, Truninger K, et al. Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. Journal of Molecular Medicine (Berlin, Germany). 84: 1015-22. PMID 17039343 DOI: 10.1007/S00109-006-0096-7 |
0.335 |
|
| 2006 |
Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardón A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, Villanueva C, Dosemeci M, Malats N, Silverman D. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain Cancer Epidemiology Biomarkers and Prevention. 15: 1696-1702. PMID 16985032 DOI: 10.1158/1055-9965.Epi-06-0038 |
0.352 |
|
| 2006 |
López-Knowles E, Hernández S, Malats N, Kogevinas M, Lloreta J, Carrato A, Tardón A, Serra C, Real FX. PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Research. 66: 7401-7404. PMID 16885334 DOI: 10.1158/0008-5472.Can-06-1182 |
0.33 |
|
| 2006 |
Hernández S, López-Knowles E, Lloreta J, Kogevinas M, Amorós A, Tardón A, Carrato A, Serra C, Malats N, Real FX. Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas Journal of Clinical Oncology. 24: 3664-3671. PMID 16877735 DOI: 10.1200/Jco.2005.05.1771 |
0.313 |
|
| 2006 |
Martín M, Simon-Assmann P, Kedinger M, Martin M, Mangeat P, Real FX, Fabre M. DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin. European Journal of Cell Biology. 85: 769-783. PMID 16762451 DOI: 10.1016/J.Ejcb.2006.02.013 |
0.333 |
|
| 2006 |
Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, et al. Hair dye use is not associated with risk for bladder cancer: Evidence from a case-control study in Spain European Journal of Cancer. 42: 1448-1454. PMID 16740387 DOI: 10.1016/J.Ejca.2006.02.009 |
0.314 |
|
| 2006 |
Witt H, Sahin-Tóth M, Landt O, Chen JM, Kähne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le Maréchal C, Akar N, Ammann RW, ... ... Real FX, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nature Genetics. 38: 668-73. PMID 16699518 DOI: 10.1038/Ng1797 |
0.317 |
|
| 2006 |
de Anta JM, Mayo C, Solé F, Salido M, Espinet B, Corzo C, Petzold M, Villa O, Serrano S, Real FX, Mayol X. Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment. International Journal of Cancer. 119: 1607-15. PMID 16671091 DOI: 10.1002/Ijc.22028 |
0.307 |
|
| 2006 |
Amillet J, Ferbus D, Real FX, Antony C, Muleris M, Gress TM, Goubin G. Characterization of human Rab20 overexpressed in exocrine pancreatic carcinoma. Human Pathology. 37: 256-263. PMID 16613320 DOI: 10.1016/J.Humpath.2005.10.017 |
0.35 |
|
| 2006 |
Roda O, Chiva C, Espuña G, Gabius HJ, Real FX, Navarro P, Andreu D. A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells Proteomics. 6: S36-41. PMID 16544279 DOI: 10.1002/Pmic.200500376 |
0.313 |
|
| 2006 |
García-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Chanock S, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 536-42. PMID 16537713 DOI: 10.1158/1055-9965.Epi-05-0749 |
0.357 |
|
| 2006 |
Pujal J, Capellá G, Real FX. The Wnt pathway is active in a small subset of pancreas cancer cell lines Biochimica Et Biophysica Acta. 1762: 73-79. PMID 16137866 DOI: 10.1016/J.Bbadis.2005.08.002 |
0.37 |
|
| 2006 |
o-Vinyals GC, Kogevinas M, Cantor KP, Hernandez S, Lopez-Knowles E, Lloreta J, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Silverman DT, Dosemeci M, Real FX, Malats N. Air Pollution and Tp53 Mutations in Bladder Cancer In Spain Epidemiology. 17. DOI: 10.1097/00001648-200611001-00972 |
0.327 |
|
| 2006 |
Cantor KP, Villanueva C, Garcia-Closas M, Silverman D, Real FX, Dosemeci M, Malats N, Yeager M, Welch R, Chanock S, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, et al. Bladder Cancer, Disinfection Byproducts, and Markers of Genetic Susceptibility in a Case-control Study from Spain Epidemiology. 17. DOI: 10.1097/00001648-200611001-00375 |
0.341 |
|
| 2006 |
Lopez-Knowles E, Hernandez S, Malats N, Kogevinas M, Lloreta J, Carrato A, Tardon A, Serra C, Real FX. Pik3Ca Mutations Are An Early Genetic Alteration Associated With Fgfr3 Mutations In Superficial Papillary Bladder Tumors European Urology Supplements. 5: 808. DOI: 10.1016/S1569-9056(06)61338-9 |
0.33 |
|
| 2006 |
Garcia-Rojo D, Malats N, Abad C, Lloreta J, Kogevinas M, Tardon A, Prera A, Serra C, Carrato A, Garcia-Closas R, Prats J, Gelabert A, Real FX. P53 In Bladder Cancer Prognosis. Results From A Prospective Multicentric Study In Spain The Journal of Urology. 5: 585-585. DOI: 10.1016/S1569-9056(06)61326-2 |
0.38 |
|
| 2005 |
Malats N, Bustos A, Nascimento CM, Fernandez F, Rivas M, Puente D, Kogevinas M, Real FX. P53 as a prognostic marker for bladder cancer: A meta-analysis and review Lancet Oncology. 6: 678-686. PMID 16129368 DOI: 10.1016/S1470-2045(05)70315-6 |
0.352 |
|
| 2005 |
García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, ... ... Real FX, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet (London, England). 366: 649-59. PMID 16112301 DOI: 10.1016/S0140-6736(05)67137-1 |
0.385 |
|
| 2005 |
Hernández S, López-Knowles E, Lloreta J, Kogevinas M, Jaramillo R, Amorós A, Tardón A, García-Closas R, Serra C, Carrato A, Malats N, Real FX. FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5444-50. PMID 16061860 DOI: 10.1158/1078-0432.Ccr-05-0122 |
0.351 |
|
| 2005 |
Porta M, Fabregat X, Malats N, Guarner L, Carrato A, Miguel Ad, Ruiz L, Jariod M, Costafreda S, Coll S, Alguacil J, Corominas JM, Solà R, Salas A, Real FX. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage Clinical & Translational Oncology. 7: 189-197. PMID 15960930 DOI: 10.1007/Bf02712816 |
0.356 |
|
| 2005 |
Anta JMd, Real FX, Mayol X. Low tumor cell density environment yields survival advantage of tumor cells exposed to MTX in vitro. Biochimica Et Biophysica Acta. 1721: 98-106. PMID 15652184 DOI: 10.1016/J.Bbagen.2004.10.006 |
0.308 |
|
| 2005 |
Garcia-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D, Kogevinas M, Dosemeci M, Figueroa J, Nilanjan C, Tardon A, Serra C, Carrato A, Reina G, Murta-Nascimento C, et al. Large-scale evaluation of candidate genes for cancer identifies common genetic variants in vascular endothelial growth factor associated with bladder cancer risk Plos Genetics. DOI: 10.1371/Journal.Pgen.0030029.Eor |
0.356 |
|
| 2004 |
Aguilar S, Corominas JM, Malats N, Pereira JA, Dufresne M, Real FX, Navarro P. Tissue Plasminogen Activator in Murine Exocrine Pancreas Cancer : Selective Expression in Ductal Tumors and Contribution to Cancer Progression American Journal of Pathology. 165: 1129-1139. PMID 15466380 DOI: 10.1016/S0002-9440(10)63374-3 |
0.344 |
|
| 2004 |
Rodolosse A, Chalaux E, Adell T, Hagège H, Skoudy A, Real FX. PTF1alpha/p48 transcription factor couples proliferation and differentiation in the exocrine pancreas [corrected]. Gastroenterology. 127: 937-49. PMID 15362048 DOI: 10.1053/J.Gastro.2004.06.058 |
0.666 |
|
| 2004 |
Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, MacDonald RJ, Civin CI, Real FX, Pack MA, Ball DW, Leach SD. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development (Cambridge, England). 131: 4213-24. PMID 15280211 DOI: 10.1242/Dev.01280 |
0.353 |
|
| 2004 |
Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, Moreno B, Lloreta J, Field SJ, Real FX, Zubiaga AM. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. The Journal of Clinical Investigation. 113: 1398-407. PMID 15146237 DOI: 10.1172/Jci18879 |
0.344 |
|
| 2004 |
Skoudy A, Rovira M, Savatier P, Martin F, León-Quinto T, Soria B, Real FX. Transforming growth factor (TGF)beta, fibroblast growth factor (FGF) and retinoid signalling pathways promote pancreatic exocrine gene expression in mouse embryonic stem cells. Biochemical Journal. 379: 749-756. PMID 14733613 DOI: 10.1042/Bj20031784 |
0.34 |
|
| 2004 |
Villanueva CM, Cantor KP, Grimalt JO, Dosemeci M, Malats N, Real FX, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Rothman N, Kogevinas M. Bladder Cancer And Exposure To Disinfection Byproducts In Water Through Ingestion, Bathing, Showering And Swimming In Pools: Findings From The Spanish Bladder Cancer Study Epidemiology. 15. DOI: 10.1097/00001648-200407000-00264 |
0.35 |
|
| 2004 |
Silverman D, Dosemeci M, Castaño-Vinyals G, Kogevinas M, Cantor KP, Malats N, Tardón A, Real FX, Garcia-Closas R, Serra C, Carrato A, Rothman N. Air Pollution And Bladder Cancer Risk In Spain Epidemiology. 15. DOI: 10.1097/00001648-200407000-00194 |
0.326 |
|
| 2003 |
Real FX. A "catastrophic hypothesis" for pancreas cancer progression. Gastroenterology. 124: 1958-1964. PMID 12806629 DOI: 10.1016/S0016-5085(03)00389-5 |
0.391 |
|
| 2003 |
Puente D, Malats N, Cecchini L, Tardón A, García-Closas R, Serra C, Carrato A, Sala M, Boixeda R, Dosemeci M, Real FX, Kogevinas M. Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. European Urology. 43: 53-62. PMID 12507544 DOI: 10.1016/S0302-2838(02)00496-7 |
0.361 |
|
| 2002 |
Real FX, Malats N, Lesca G, Porta M, Chopin S, Lenoir GM, Sinilnikova O. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer Gut. 50: 653-657. PMID 11950811 DOI: 10.1136/Gut.50.5.653 |
0.385 |
|
| 2002 |
Porta M, Malats N, Corominas JM, Rifà J, Piñol JL, Real FX. Generalizing Molecular Results Arising from Incomplete Biological Samples:: Expected Bias and Unexpected Findings Annals of Epidemiology. 12: 7-14. PMID 11750234 DOI: 10.1016/S1047-2797(01)00267-8 |
0.317 |
|
| 2001 |
Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR, Gress T, Bassi C, Klöppel G, Kalthoff H, Ungefroren H, Löhr M, Scarpa A. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Archiv : An International Journal of Pathology. 439: 798-802. PMID 11787853 DOI: 10.1007/S004280100474 |
0.326 |
|
| 2001 |
López-Ferrer A, Curull V, Barranco C, Garrido M, Lloreta J, Real FX, Bolós Cd. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. American Journal of Respiratory Cell and Molecular Biology. 24: 22-29. PMID 11152646 DOI: 10.1165/Ajrcmb.24.1.4294 |
0.324 |
|
| 2001 |
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut. 48: 70-4. PMID 11115825 DOI: 10.1136/Gut.48.1.70 |
0.36 |
|
| 2000 |
Torà M, Barberá VM, Real FX. Detection of HuD transcripts by means of reverse transcriptase and polymerase chain reaction: implications for the detection of minimal residual disease in patients with small cell lung cancer. Cancer Letters. 161: 157-164. PMID 11090964 DOI: 10.1016/S0304-3835(00)00577-2 |
0.345 |
|
| 2000 |
Porta M, Costafreda S, Malats N, Guarner L, Soler M, Gubern JM, García-Olivares E, Andreu M, Salas A, Corominas JM, Alguacil J, Carrato A, Rifà J, Real FX. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology European Journal of Epidemiology. 16: 533-541. PMID 11049097 DOI: 10.1023/A:1007692408457 |
0.302 |
|
| 2000 |
Barberá VM, Martín M, Mariñoso L, Munné A, Carrato A, Real FX, Fabre M. The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression. Biochimica Et Biophysica Acta. 1502: 283-296. PMID 11040453 DOI: 10.1016/S0925-4439(00)00054-5 |
0.361 |
|
| 1999 |
Porta M, Malats N, Guarner L, Carrato A, Rifà J, Salas A, Corominas JM, Andreu M, Real FX. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Journal of Epidemiology and Community Health. 53: 702-709. PMID 10656099 DOI: 10.1136/Jech.53.11.702 |
0.339 |
|
| 1999 |
Muriné A, Fabre M, Mariñoso ML, Gallén M, Real FX. Nuclear β-catenin in Colorectal Tumors: To Freeze or Not To Freeze?: Journal of Histochemistry and Cytochemistry. 47: 1089-1094. PMID 10424893 DOI: 10.1177/002215549904700813 |
0.308 |
|
| 1999 |
Navarro E, Espinosa L, Adell T, Torà M, Berrozpe G, Real FX. Expressed sequence tag (EST) phenotyping of HT-29 cells: cloning of ser/thr protein kinase EMK1, kinesin KIF3B, and of transcripts that include Alu repeated elements. Biochimica Et Biophysica Acta. 1450: 254-264. PMID 10395937 DOI: 10.1016/S0167-4889(99)00051-8 |
0.665 |
|
| 1999 |
Fabre M, Martin M, Ulloa F, Real FX. In vitro analysis of the role of DCC in mucus-secreting intestinal differentiation† International Journal of Cancer. 81: 799-807. PMID 10328236 DOI: 10.1002/(Sici)1097-0215(19990531)81:5<799::Aid-Ijc22>3.0.Co;2-W |
0.418 |
|
| 1999 |
Navarro E, Espinosa L, Adell T, Torà M, Berrozpe G, Real FX. Erratum to: ‘Expressed sequence tag (EST) phenotyping of HT-29 cells: cloning of ser/thr protein kinase EMK1, kinesin KIF3B, and of transcripts that include Alu repeated elements’: [Biochimica et Biophysica Acta, 1450 (1999) 254–264]1 Biochimica Et Biophysica Acta. 1452: 322. DOI: 10.1016/S0167-4889(99)00136-6 |
0.641 |
|
| 1998 |
Soler M, Porta M, Malats N, Guarner L, Costafreda S, Gubern JM, Garcı́a-Olivares E, Andreu M, Real FX. Learning from case reports: Diagnostic issues in an epidemiologic study of pancreatic cancer Journal of Clinical Epidemiology. 51: 1215-1221. PMID 10086813 DOI: 10.1016/S0895-4356(98)00130-9 |
0.397 |
|
| 1998 |
Paciucci R, Vilá MR, Adell T, Díaz VM, Torà M, Nakamura T, Real FX. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. The American Journal of Pathology. 153: 201-12. PMID 9665481 DOI: 10.1016/S0002-9440(10)65561-7 |
0.703 |
|
| 1998 |
Bolòs Cd, Gumà M, Barranco C, Garrido M, Kim YS, Real FX. MUC6 expression in breast tissues and cultured cells: abnormal expression in tumors and regulation by steroid hormones. International Journal of Cancer. 77: 193-199. PMID 9650551 DOI: 10.1002/(Sici)1097-0215(19980717)77:2<193::Aid-Ijc4>3.0.Co;2-L |
0.342 |
|
| 1998 |
Paciucci R, Torà M, Díaz VM, Real FX. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene. 16: 625-33. PMID 9482108 DOI: 10.1038/Sj.Onc.1201564 |
0.375 |
|
| 1997 |
Graus F, Dalmou J, Reñé R, Tora M, Malats N, Verschuuren JJ, Cardenal F, Viñolas N, Garcia del Muro J, Vadell C, Mason WP, Rosell R, Posner JB, Real FX. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 2866-72. PMID 9256130 DOI: 10.1200/Jco.1997.15.8.2866 |
0.321 |
|
| 1997 |
Malats N, Porta M, Corominas JM, Piñol JL, Rifà J, Real FX. Ki-ras mutations in exocrine pancreatic cancer : Association with clinico-pathological characteristics and with tobacco and alcohol consumption International Journal of Cancer. 70: 661-667. PMID 9096646 DOI: 10.1002/(Sici)1097-0215(19970317)70:6<661::Aid-Ijc6>3.0.Co;2-T |
0.323 |
|
| 1997 |
Tora M, Graus F, Bolos Cd, Real FX. Cell surface expression of paraneoplastic encephalomyelitis/sensory neuronopathy-associated Hu antigens in small-cell lung cancers and neuroblastomas Neurology. 48: 735-741. PMID 9065557 DOI: 10.1212/Wnl.48.3.735 |
0.329 |
|
| 1997 |
Rosenfeld MR, Malats N, Schramm L, Graus F, Cardenal F, Viñolas N, Rosell R, Torà M, Real FX, Posner JB, Dalmau J. Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. Journal of the National Cancer Institute. 89: 381-5. PMID 9060960 DOI: 10.1093/Jnci/89.5.381 |
0.309 |
|
| 1996 |
Torres MJ, Ruiz-Cabello F, Skoudy A, Berrozpe G, Jimenez P, Serrano A, Real FX, Garrido F. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line Tissue Antigens. 47: 372-381. PMID 8795137 DOI: 10.1111/J.1399-0039.1996.Tb02572.X |
0.332 |
|
| 1996 |
Francí C, Egea G, Arribas R, Reuser AJJ, Real FX. Lysosomal alpha-glucosidase: cell-specific processing and altered maturation in HT-29 colon cancer cells. Biochemical Journal. 314: 33-40. PMID 8660303 DOI: 10.1042/Bj3140033 |
0.31 |
|
| 1996 |
Paciucci R, Berrozpe G, Torà M, Navarro E, Herreros AGd, Real FX. Isolation of tissue‐type plasminogen activator, cathepsin H, and non‐specific cross‐reacting antigen from SK‐PC‐1 pancreas cancer cells using subtractive hybridization Febs Letters. 385: 72-76. PMID 8641471 DOI: 10.1016/0014-5793(96)00352-3 |
0.378 |
|
| 1995 |
Balagué C, Audié J, Porchet N, Real FX. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology. 109: 953-964. PMID 7657125 DOI: 10.1016/0016-5085(95)90406-9 |
0.376 |
|
| 1995 |
De Bolós C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach Gastroenterology. 109: 723-734. PMID 7657100 DOI: 10.1016/0016-5085(95)90379-8 |
0.303 |
|
| 1995 |
Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators. Journal of Clinical Oncology. 13: 1679-1686. PMID 7602358 DOI: 10.1200/Jco.1995.13.7.1679 |
0.301 |
|
| 1994 |
Balagué C, Gambús G, Carrato C, Porchet N, Aubert J, Kim YS, Real FX. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines Gastroenterology. 106: 1054-1061. PMID 8143972 DOI: 10.1016/0016-5085(94)90767-6 |
0.412 |
|
| 1994 |
Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. International Journal of Cancer. 58: 185-91. PMID 8026879 DOI: 10.1002/Ijc.2910580207 |
0.353 |
|
| 1994 |
Carrato C, Balague C, de Bolos C, Gonzalez E, Gambus G, Planas J, Perini JM, Andreu D, Real FX. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology. 107: 160-72. PMID 8020658 DOI: 10.1016/0016-5085(94)90073-6 |
0.326 |
|
| 1994 |
Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer Journal of Clinical Epidemiology. 47: 1069-1079. PMID 7730910 DOI: 10.1016/0895-4356(94)90123-6 |
0.304 |
|
| 1993 |
Malats N, Real FX, Porta M. DDT and Pancreatic Cancer Journal of the National Cancer Institute. 85: 328-328. PMID 8426376 DOI: 10.1093/Jnci/85.4.328 |
0.39 |
|
| 1993 |
Klingel R, Real FX, Büschenfelde K-Mz, Dippold WG. Expression of epithelial antigens EPM-1 and EXO-1 in normal, transitional, inflammatory and neoplastic colorectal mucosa European Journal of Cancer. 29: 1723-1728. PMID 8398302 DOI: 10.1016/0959-8049(93)90113-T |
0.309 |
|
| 1993 |
Real FX, Vilá MR, Skoudy A, Ramaekers FCS, Corominas JM. Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer International Journal of Cancer. 54: 720-727. PMID 7686885 DOI: 10.1002/Ijc.2910540503 |
0.39 |
|
| 1992 |
Real FX, Xu M, RosaVilá M, Bolós Cd. Intestinal brush-border-associated enzymes: co-ordinated expression in colorectal cancer. International Journal of Cancer. 51: 173-181. PMID 1349006 DOI: 10.1002/Ijc.2910510203 |
0.4 |
|
| 1991 |
Schuessler MH, Pintado S, Welt S, Real FX, Xu M, Melamed MR, Lloyd KO, Oettgen HF. Blood group and blood group-related antigens in normal pancreas and pancreas cancer : Enhanced expression of precursor type 1, Tn, and sialyl-Tn in pancreas cancer International Journal of Cancer. 47: 180-187. PMID 1988363 DOI: 10.1002/Ijc.2910470204 |
0.323 |
|
| 1991 |
Real FX, Egea G, Francí C, Schüssler MH, Xu M, Welt S. Mucin production by colon cancer cells cultured in serum-free medium. International Journal of Cancer. 49: 787-795. PMID 1718913 DOI: 10.1002/Ijc.2910490525 |
0.324 |
|
| 1989 |
Xu M, Real FX, Welt S, Schüssler MH, Oettgen HF, Old LJ. Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. International Journal of Cancer. 44: 985-989. PMID 2481651 DOI: 10.1002/Ijc.2910440607 |
0.361 |
|
| 1987 |
Houghton AN, Real FX, Davis LJ, Cordon-Cardo C, Old LJ. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. The Journal of Experimental Medicine. 165: 812-29. PMID 3102678 DOI: 10.1084/Jem.165.3.812 |
0.309 |
|
| 1986 |
Rettig WJ, Real FX, Spengler BA, Biedler JL, Old LJ. Human melanoma proteoglycan: expression in hybrids controlled by intrinsic and extrinsic signals. Science (New York, N.Y.). 231: 1281-4. PMID 3633135 DOI: 10.1126/Science.3633135 |
0.304 |
|
| Show low-probability matches. |